Advertisement

Topics

Ester Neurosciences Ltd Company Profile

12:08 EST 16th December 2018 | BioPortfolio

Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, Alzheimer's disease, multiple sclerosis and acute stress reactions. Ester's unique platform technology is based on the company's breakthrough discoveries relating to cholinergic neuromodulation and its involvement in the diseased state.

Location

Ackerstein Towers, Bldg. B. 10th Flr 11 Hamanofim St., Herzlia Pituach 46725 POBox 2206
Herzlia Pituach
46120
Israel

Contact

Phone: 972-9-960 1919
Fax: 972-9-954 2266
Email: info@esterneuro.com


News Articles [68 Associated News Articles listed on BioPortfolio]

ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Third Quarter 2018 Results

TORONTO and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody t...

ProMIS Neurosciences Inc.: ProMIS Neurosciences Identifies Novel Targets on Tau Protein Involved in the Development of Alzheimer's Disease and Other Dementias

ProMIS' proprietary discovery platform generates additional potential opportunities for pharma partnering TORONTO and CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ...

Minerva Neurosciences, Inc: Minerva Neurosciences to Present at Evercore ISI HealthCONx Conference on November 28, 2018

WALTHAM, Mass., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat ...

Minerva Neurosciences, Inc: Minerva Neurosciences Announces Findings Showing Effect of Roluperidone on Brain-Derived Neurotrophic Factor (BDNF)

WALTHAM, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nerv...

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Second Quarter 2018 Financial Results and Business Updates

Five ongoing late-stage trials on track for data readouts in 2019WALTHAM, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical com...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

Management to host conference call WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developmen...

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Third Quarter 2018 Financial Results and Business Updates

Data readouts from five ongoing late-stage trials expected in 2019 WALTHAM, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical c...

Magnolia Neurosciences Launches with $31 Million

Magnolia Neurosciences Corporation, co-founded by Accelerator Life Science Partners and The University of Texas MD Anderson Cancer Center, launched with a $31 million Series A financing.

PubMed Articles [253 Associated PubMed Articles listed on BioPortfolio]

Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin.

Human serum albumin (HSA) is a major plasma protein and binding of drugs with this plasma protein has a great importance. It possess esterase activity which can cleave the drugs containing ester bond ...

Photoredox-Catalyzed Cascade Radical Cyclization of Ester Arylpropiolates with CF3SO2Cl to Construct 3-Trifluoromethyl-Coumarin Derivatives.

We reported a high-efficiency method to construct 3-trifluoromethy coumarins using CF3SO2Cl as the trifluoromethyl radical source with ester 3-arylpropiolates. The reaction incorporated a cascade cycl...

2-Benzoylpyridine ligand complexation with gold critical for propargyl ester-based protein labeling.

Previously, Au(III) complexes coordinated with 2-benzoylpyridine ligand, BPy-Au, were prebound to a protein and used to discover a novel protein-directed labelling approach with propargyl ester functi...

Shape-Persistent Tetrahedral 4+6 Boronic ester Cages with different Degree of Fluoride Substitution.

In recent years the interest of shape-persistent organic cage compounds synthesized by dynamic covalent chemistry (DCC) has risen, because these cages are potentially interesting for gas sorption or -...

NeurHistAlert 24.

Clinical Trials [77 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women

The objective of this study was to evaluate and compare the acute bioavailability of EPA and DHA in wax ester form provided as a dietary supplement compared to a well-studied and defined e...

Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester

The purpose of the study is to investigate the cholesterol lowering efficacy of a cereal based snack bar with added plant stanol ester when used between meals as part of a habitual diet by...

A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management

This is a randomized, double blind, placebo-controlled, single dose study to assess the safety, efficacy and pharmacokinetics of intramuscular sebacoyl dinalbuphine ester (SDE) for post-he...

Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet

Since it is very difficult to have the real thing (Mediterranean diet) we need to find an alternative to reduce cardiovascular disease (CVD) risk in subjects with moderate hypercholesterol...

Ketone Esters for Optimization of Cognitive Performance in Hypoxia

This study will investigate the effects of ketone ester drinks on cognitive performance in hypoxia.

Companies [58 Associated Companies listed on BioPortfolio]

Ester Neurosciences Ltd

Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as m...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

Ester-C

Nautilus Neurosciences, Inc.

Nautilus Neurosciences, Inc. is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with medically relevant products and services ...

NBTY, Inc.

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the worl...

More Information about "Ester Neurosciences Ltd" on BioPortfolio

We have published hundreds of Ester Neurosciences Ltd news stories on BioPortfolio along with dozens of Ester Neurosciences Ltd Clinical Trials and PubMed Articles about Ester Neurosciences Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ester Neurosciences Ltd Companies in our database. You can also find out about relevant Ester Neurosciences Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record